HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eddy Pasquier Selected Research

Drug Combinations

1/2019Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data.
12/2014Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer.
10/2011Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eddy Pasquier Research Topics

Disease

36Neoplasms (Cancer)
08/2022 - 10/2004
6Neuroblastoma
01/2017 - 10/2013
5Breast Neoplasms (Breast Cancer)
01/2019 - 10/2007
5Neoplasm Metastasis (Metastasis)
04/2014 - 10/2004
4Hemangiosarcoma (Angiosarcoma)
04/2016 - 01/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2021 - 10/2007
3Prostatic Neoplasms (Prostate Cancer)
01/2014 - 02/2009
2Glioma (Gliomas)
11/2021 - 01/2016
2Lung Neoplasms (Lung Cancer)
01/2017 - 04/2014
2Triple Negative Breast Neoplasms
12/2014 - 10/2011
1Medulloblastoma
08/2022
1Carcinogenesis
11/2021
1Glioblastoma (Glioblastoma Multiforme)
12/2020
1Brain Neoplasms (Brain Tumor)
12/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2020
1Rhabdomyosarcoma
10/2020
1Sarcoma (Soft Tissue Sarcoma)
01/2019
1Hypotrichosis
01/2019
1Telangiectasis (Telangiectasia)
01/2019
1Edema (Dropsy)
01/2019
1Vascular Diseases (Vascular Disease)
01/2019
1Hemangioma (Angioma)
01/2019
1Lymphedema (Milroy Disease)
01/2019
1Vascular Neoplasms (Neoplasms, Vascular)
01/2019
1Malignant Mesothelioma
03/2018
1Inflammation (Inflammations)
01/2017
1Adenocarcinoma
11/2015
1Disease Resistance
07/2014
1Hepatocellular Carcinoma (Hepatoma)
01/2014
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2011
1Multiple Myeloma
05/2010
1Meningeal Carcinomatosis
08/2009
1Subdural Hematoma (Subdural Hemorrhage)
08/2009
1Anemia
07/2008
1Neutropenia
07/2008

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
08/2022 - 08/2010
6Propranolol (Inderal)FDA LinkGeneric
01/2019 - 10/2011
4Paclitaxel (Taxol)FDA LinkGeneric
04/2013 - 10/2004
3Proteins (Proteins, Gene)FDA Link
12/2020 - 02/2016
3Drug CombinationsIBA
01/2019 - 10/2011
3Vinblastine (Vinblastine Sulfate)FDA Link
04/2016 - 02/2011
2beta Adrenergic ReceptorsIBA
08/2022 - 01/2019
2Adrenergic Receptors (Adrenergic Receptor)IBA
08/2022 - 04/2016
2Phosphotransferases (Kinase)IBA
12/2020 - 01/2017
2GemcitabineFDA Link
11/2020 - 01/2017
2Methotrexate (Mexate)FDA LinkGeneric
04/2016 - 01/2011
2Long Noncoding RNAIBA
02/2016 - 04/2014
2Hormones (Hormone)IBA
11/2015 - 05/2010
2Antineoplastic Agents (Antineoplastics)IBA
01/2012 - 09/2007
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2011 - 07/2008
2TubulinIBA
10/2007 - 09/2007
1Superoxides (Superoxide)IBA
08/2022
1Histones (Histone)IBA
11/2021
1Mitogen-Activated Protein Kinase 14IBA
12/2020
1Mebendazole (Anti-Worm)FDA Link
12/2020
1Electron Transport Complex I (NADH-CoQ Reductase)IBA
11/2020
1Phenformin (Fenformin)IBA
11/2020
1Messenger RNA (mRNA)IBA
11/2020
1CaspasesIBA
01/2019
1Adrenergic Antagonists (Antiadrenergic Agents)IBA
01/2019
1SOXF Transcription FactorsIBA
01/2019
1PolyphenolsIBA
01/2017
1Dextrans (Dextran)FDA Link
01/2017
1CopperIBA
01/2017
1Catechin (Z 7300)IBA
01/2017
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2016
1ImmunosorbentsIBA
02/2016
1Small Interfering RNA (siRNA)IBA
02/2016
1Conditioned Culture MediaIBA
02/2016
1EnzymesIBA
02/2016
1Irinotecan (Camptosar)FDA LinkGeneric
01/2016
1Bevacizumab (Avastin)FDA Link
01/2016
1Mannich BasesIBA
11/2015
1phenoxodiolIBA
11/2015
1Biological ProductsIBA
11/2015
1IsoflavonesIBA
11/2015
1daidzeinIBA
11/2015
1SaltsIBA
10/2014
1Fluorouracil (Carac)FDA LinkGeneric
04/2013
1LuciferasesIBA
10/2011
1Vincristine (Oncovin)FDA LinkGeneric
01/2011
12- methoxyoestra- 1,3,5(10),16- tetraene- 3- carboxamideIBA
05/2010
12-MethoxyestradiolIBA
05/2010
1AndrogensIBA
02/2009
1Etoposide (VP 16)FDA LinkGeneric
07/2008
1Celecoxib (Celebrex)FDA Link
07/2008
1DNA (Deoxyribonucleic Acid)IBA
10/2007
1A-Form DNA (A-DNA)IBA
10/2007

Therapy/Procedure

19Drug Therapy (Chemotherapy)
11/2021 - 02/2006
17Therapeutics
08/2022 - 03/2006
1Radiotherapy
08/2022
1Aftercare (After-Treatment)
01/2017
1Biological Therapy
12/2015
1Immunotherapy
12/2015
1Combination Drug Therapy (Combination Chemotherapy)
01/2015
1Erythrocyte Transfusion
07/2008